The second edition provides an improved basis for policy debate and informed decision-making at a critical time for global health.
Roles: Everyone: All Users
Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health, Human Rights and Democracy, Science, Technology, and Innovation
Today, more than 20 leading biopharmaceutical companies are announcing the launch of the AMR Action Fund that will invest in developing innovative antibacterial treatments. The Fund aims to bring 2-4 new treatments to patients by 2030. This initiative is a significant step towards addressing the current crisis in antibacterial treatment development.
Results 1 - 2 of 2